Dr. Alan Nichol, MD
Claim this profileBC Cancer - Vancouver
Studies Metastases
Studies Brain Cancer
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Alan Nichol, MD is currently running
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
More about Alan Nichol, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Alan Nichol, MD has experience with
- RAPid SimPLE Targeted Radiation Treatment
- No Radiation
- Radiation
- Hippocampal-avoidant (HA-WBRT) Radiotherapy
- Memantine
- Stereotactic Radiosurgery (SRS)
Breakdown of trials Alan Nichol, MD has run
Metastases
Brain Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alan Nichol, MD specialize in?
Alan Nichol, MD focuses on Metastases and Brain Cancer. In particular, much of their work with Metastases has involved Stage IV patients, or patients who are undergoing treatment.
Is Alan Nichol, MD currently recruiting for clinical trials?
Yes, Alan Nichol, MD is currently recruiting for 3 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Alan Nichol, MD has studied deeply?
Yes, Alan Nichol, MD has studied treatments such as RAPid SimPLE Targeted Radiation Treatment, No Radiation, Radiation.
What is the best way to schedule an appointment with Alan Nichol, MD?
Apply for one of the trials that Alan Nichol, MD is conducting.
What is the office address of Alan Nichol, MD?
The office of Alan Nichol, MD is located at: BC Cancer - Vancouver, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BC Cancer - Vancouver.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.